Bryan Roberts Insider Buy Transaction
The director of Castlight Health Inc (NYSE:CSLT)
Castlight Health Inc Stock Rating, Sentiment and Fundamentals
The substantial size of the deal could indicate that Mr. Bryan Roberts is positive about the stock price of Castlight Health Inc. The nine top stock analysts reporting on the stock forecast $-0.70/share earnings for 2015. This gives it a Price to Earnings ratio of NaN. They also anticipate a growth rate year over year of more than 35.00%.
|Rating & Sentiment|
|Hedge Funds Sentiment:||BUY|
|Earnings + FCF Trend:||BUY|
* Read How Our Stock Ratings System Works
Within the last 200 days Castlight Health Inc’s share price has dived 54.07 % and today is in firm downtrend. Octafinance rate the stock “NEUTRAL”, because our tested time-momentum model doesn’t agree with Bryan Roberts’s purchase.
Price Chart of Castlight Health NYSE:CSLT Stock
Source: RightEdgeSystems, Yahoo Split & Dividend Adjusted Data and OctaFinance Interpretations
As the legendary Michael Platt, a stock market legend, said, best risk-adjusted returns are made through a combination of fundamental & technical analysis. But as our analysis says, this is not evidently with this company.
Hedge Funds Ownership
As of Q2 2015, 97 hedge funds and institutional investors hold shares in Castlight Health Inc. The institutional ownership of the company in Q2 2015 is high, at 43.67 % of the shares outstanding. Its down 6.67 % from Q1 2015. These investment managers decreased the total shares they own by 2.95 million to 41.30 million this quarter. There were 24 funds that created new positions and 44 funds that added to their positions. A total of 13 funds closed their positions in Castlight Health Inc and 14 reduced their holdings.
Franklin Street Advisors Inc Nc had the greatest investment with ownership of 28,300 shares as of Q2 2015 for 0.04% of the fund’s portfolio. Gagnon Advisors Llc is another positive institutional manager owning 557,822 shares of the company or 3.11% of their stocks portfolio. The stock is also 2.73% of the fund’s AUM. Gagnon Securities Llc have 2.78% of their stock portfolio invested in the company for 864,527 shares. Moreover, The New York-based fund Allen Operations Llc revealed it had purchased a stake worth 1.34% of the fund’s stock portfolio in the company. Wellcome Trust Ltd (The) As Trustee Of The Wellcome Trust was also a big supporter of the firm, possessing 6.57 million shares. Castlight Health Inc is 1.08% of the fund’s stock portfolio.
Castlight Health NYSE:CSLT Company Profile
Castlight Health, Inc. is a provider of cloud-based software that enables enterprises to understand and manage health care spending as a business investment, and help employees and their families make medical decisions. The Company’s Enterprise Healthcare Cloud provides information to its employees, implementing technology-enabled benefit designs and integrating systems and applications. The Company deploys consumer-oriented applications that deliver employee engagement and enable employers to integrate benefit programs into one platform available to employees and their families. The Company’s Enterprise Healthcare Cloud offering transforms data into transparent and useful information. This data include external data, which it obtains from sources, such as health care providers, insurance companies, governmental agencies and quality-monitoring organizations, as well as internal data generated through the usage of its applications.
Company Website: Castlight Health
Now its market value is: $379.52 million and it has 93.25 million shares outstanding. The company has 345 employees. At the moment the company has 44.70% shareholders and the institutional ownership is 44.70%. Castlight Health Inc was formed in Delaware on 2008-01-31. The stock closed at $4.01 yesterday and it had average 2 days volume of 68897 shares. It is down from the 30 days average shares volume of 111321. Castlight Health Inc has a 52 weeks low of $3.60 and a 250 days high of $13.43. The current price is below the 200 days SMA. Castlight Health Inc last issued its quarterly earnings report on 11/04/2015. The company reported -0.2 EPS for the quarter, above the consensus estimate of -0.21 by 0.01. The company had a revenue of 19.54 million for 9/30/2015 and 18.51 million for 6/30/2015. Therefore, the revenue was 1.03 million up.
Bryan Roberts is also director of Zeltiq Aesthetics Inc, Ironwood Pharmaceuticals Inc, Achaogen Inc, Vitae Pharmaceuticals, Inc, Athenahealth Inc, Xenoport Inc, Sirna Therapeutics Inc, Intarcia Therapeutics, Inc, 10 percent owner of Avalanche Biotechnologies, Inc., Anacor Pharmaceuticals, Inc., Chelsea Therapeutics International, Ltd., Neurocrine Biosciences Inc.
* Venrock Associates V – L.P. (“VA5”) holds an aggregate of 1 – 133 – 948 shares – Venrock Partners V – L.P. (“VP5”) holds an aggregate of 96 – 139 shares and Venrock Entrepreneurs Fund V – L.P. (“VEF5”) holds an aggregate of 26 – 643 shares. Venrock Management V – LLC – VEF Management V – LLC and Venrock Partners Management V – LLC (collectively – the “Venrock GP Entities”) are the sole general partners of VA5 – VEF5 and VP5 (collectively – the “Funds”) – respectively – and may be deemed to beneficially own these shares. Dr. Roberts is a member of the Venrock GP Entities and may be deemed to beneficially own these shares. Dr. Roberts and the Venrock GP Entities expressly disclaim beneficial ownership over these shares except to the extent of their indirect pecuniary interests therein.
* The reporting person is a member of VR Management – LLC (the “Management Company”). Under an agreement between the reporting person and the Management Company – the reporting person is deemed to hold the reported shares for the sole benefit of the Management Company and must exercise the reported shares solely upon the direction of the Management Company – which is entitled to the shares. The Management Company may be deemed the indirect beneficial owner of the reported shares – and the reporting person may be deemed the indirect beneficial owner of the reported shares through his interest in the Management Company. The reporting person disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein.
Castlight Health - Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.